Beneficial effect of albuterol in congenital myasthenic syndrome with epsilon‐subunit mutations
Authors:
- 30 June 2011
- journal article
- case report
- Published by Wiley in Muscle & Nerve
- Vol. 44 (2) , 289-291
Abstract
Mutations in the epsilon subunit of the acetylcholine receptor (AChR) are a common cause of congenital myasthenic syndrome (CMS). Patients are usually treated with acetylcholinesterase inhibitors and 3,4‐diaminopyridine with modest clinical benefit. We report 2 patients with CMS due to mutations in the AChR epsilon subunit. The first patient carries two heterozygous frameshift mutations, ε127ins5 and ε1293insG. The second patient is homozygous for the εC142Y mutation that curtails AChR expression to 22% of wild‐type in HEK cells. Treatment with pyridostigmine and 3,4‐diaminopyridine had a limited beneficial effect in the first patient, and the second patient became wheelchair‐bound during therapy. The additional use of albuterol produced dramatic improvement in strength and in activities of daily living in both patients. The efficacy and safety of albuterol in patients who harbor identified low‐expressor or null mutations in the epsilon or other subunits of AChR merits a well‐designed clinical trial. Muscle Nerve, 2011Keywords
This publication has 12 references indexed in Scilit:
- The potential use of ephedrine in Lambert-Eaton myasthenic syndromeJournal of Neurology, 2008
- Clinical features of the DOK7 neuromuscular junction synaptopathyBrain, 2007
- Congenital endplate acetylcholinesterase deficiency responsive to ephedrineNeurology, 2005
- Congenital myasthenic syndromes: Progress over the past decadeMuscle & Nerve, 2002
- Congenital Myasthenic Syndromes due to Heteroallelic Nonsense/Missense Mutations in the Acetylcholine Receptor Subunit Gene: Identification and Functional Characterization of Six New MutationsHuman Molecular Genetics, 1997
- Block of the endplate acetylcholine receptor channel by the sympathomimetic agents ephedrine, pseudoephedrine, and albuterolBrain Research, 1996
- Ephedrine: effects on neuromuscular transmissionBrain Research, 1993
- Effect of ephedrine on muscle weakness in a model of myasthenia gravis in ratsNeuropharmacology, 1993
- Myasthenia gravis: Review of diagnosis and managementMuscle & Nerve, 1978
- THE EFFECT OF EPHEDRINE IN THE TREATMENT OF MYASTHENIA GRAVIS: SECOND REPORT1933